APOE and Alzheimer disease: The better-known genetic risk factor in late-onset Ad is the presence of the ε4 allele of the apolipoprotein E gene, although the biochemical networks that affect late-onset Ad comprise a broad spectrum of metabolic pathways (Recabarren and Alarcon 2017).